Does the media refer more to HAE or PRCT?

In the previous week, PROCEPT BioRobotics had 17 more articles in the media than Haemonetics. MarketBeat recorded 38 mentions for PROCEPT BioRobotics and 21 mentions for Haemonetics. Haemonetics' average media sentiment score of 0.67 beat PROCEPT BioRobotics' score of 0.24 indicating that Haemonetics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Haemonetics 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PROCEPT BioRobotics 11 Very Positive mention(s) 0 Positive mention(s) 25 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media refer more to PRCT or LIVN?

In the previous week, PROCEPT BioRobotics had 35 more articles in the media than LivaNova. MarketBeat recorded 38 mentions for PROCEPT BioRobotics and 3 mentions for LivaNova. LivaNova's average media sentiment score of 1.08 beat PROCEPT BioRobotics' score of 0.24 indicating that LivaNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PROCEPT BioRobotics 11 Very Positive mention(s) 0 Positive mention(s) 25 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral LivaNova 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ITGR or PRCT?

In the previous week, PROCEPT BioRobotics had 14 more articles in the media than Integer. MarketBeat recorded 38 mentions for PROCEPT BioRobotics and 24 mentions for Integer. Integer's average media sentiment score of 0.57 beat PROCEPT BioRobotics' score of 0.24 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 11 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PROCEPT BioRobotics 11 Very Positive mention(s) 0 Positive mention(s) 25 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media prefer IRTC or PRCT?

In the previous week, PROCEPT BioRobotics had 33 more articles in the media than iRhythm Technologies. MarketBeat recorded 38 mentions for PROCEPT BioRobotics and 5 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.08 beat PROCEPT BioRobotics' score of 0.24 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PROCEPT BioRobotics 11 Very Positive mention(s) 0 Positive mention(s) 25 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media favor PLSE or PRCT?

In the previous week, PROCEPT BioRobotics had 27 more articles in the media than Pulse Biosciences. MarketBeat recorded 38 mentions for PROCEPT BioRobotics and 11 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 1.14 beat PROCEPT BioRobotics' score of 0.24 indicating that Pulse Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulse Biosciences 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PROCEPT BioRobotics 11 Very Positive mention(s) 0 Positive mention(s) 25 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

PROCEPT BioRobotics (PRCT) Competitors

$20.83 +0.23 (+1.12%)

As of 08/28/2026 04:00 PM Eastern

Compare

PRCT vs. HAE, LIVN, ITGR, IRTC, and PLSE

Should you buy PROCEPT BioRobotics stock or one of its competitors? PROCEPT BioRobotics's main competitors and comparable companies include Haemonetics (HAE), LivaNova (LIVN), Integer (ITGR), iRhythm Technologies (IRTC), and Pulse Biosciences (PLSE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does PROCEPT BioRobotics compare to Haemonetics?

Haemonetics (NYSE:HAE) and PROCEPT BioRobotics (NASDAQ:PRCT) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

Haemonetics has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haemonetics	$1.33B	3.54	$97.31M	$2.04	50.90
PROCEPT BioRobotics	$308.05M	3.87	-$95.57M	-$1.94	N/A

99.7% of Haemonetics shares are held by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are held by institutional investors. 2.1% of Haemonetics shares are held by insiders. Comparatively, 4.0% of PROCEPT BioRobotics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Haemonetics has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, PROCEPT BioRobotics has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market.

Haemonetics presently has a consensus target price of $97.56, suggesting a potential downside of 6.04%. PROCEPT BioRobotics has a consensus target price of $28.00, suggesting a potential upside of 34.42%. Given PROCEPT BioRobotics' higher possible upside, analysts clearly believe PROCEPT BioRobotics is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
PROCEPT BioRobotics	2 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.19

Haemonetics has a net margin of 7.12% compared to PROCEPT BioRobotics' net margin of -32.53%. Haemonetics' return on equity of 27.55% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haemonetics	7.12%	27.55%	9.65%
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%

In the previous week, PROCEPT BioRobotics had 17 more articles in the media than Haemonetics. MarketBeat recorded 38 mentions for PROCEPT BioRobotics and 21 mentions for Haemonetics. Haemonetics' average media sentiment score of 0.67 beat PROCEPT BioRobotics' score of 0.24 indicating that Haemonetics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haemonetics	8 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PROCEPT BioRobotics	11 Very Positive mention(s)	0 Positive mention(s)	25 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Haemonetics beats PROCEPT BioRobotics on 11 of the 16 factors compared between the two stocks.

How does PROCEPT BioRobotics compare to LivaNova?

PROCEPT BioRobotics (NASDAQ:PRCT) and LivaNova (NASDAQ:LIVN) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

In the previous week, PROCEPT BioRobotics had 35 more articles in the media than LivaNova. MarketBeat recorded 38 mentions for PROCEPT BioRobotics and 3 mentions for LivaNova. LivaNova's average media sentiment score of 1.08 beat PROCEPT BioRobotics' score of 0.24 indicating that LivaNova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PROCEPT BioRobotics	11 Very Positive mention(s)	0 Positive mention(s)	25 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
LivaNova	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PROCEPT BioRobotics has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market.

PROCEPT BioRobotics has higher earnings, but lower revenue than LivaNova. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PROCEPT BioRobotics	$308.05M	3.87	-$95.57M	-$1.94	N/A
LivaNova	$1.47B	3.01	-$242.47M	$3.38	23.76

89.5% of PROCEPT BioRobotics shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 4.0% of PROCEPT BioRobotics shares are owned by insiders. Comparatively, 0.4% of LivaNova shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

PROCEPT BioRobotics currently has a consensus target price of $28.00, indicating a potential upside of 34.42%. LivaNova has a consensus target price of $83.50, indicating a potential upside of 3.96%. Given PROCEPT BioRobotics' higher possible upside, research analysts plainly believe PROCEPT BioRobotics is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PROCEPT BioRobotics	2 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.19
LivaNova	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.55

LivaNova has a net margin of 12.82% compared to PROCEPT BioRobotics' net margin of -32.53%. LivaNova's return on equity of 16.35% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%
LivaNova	12.82%	16.35%	7.76%

Summary

LivaNova beats PROCEPT BioRobotics on 10 of the 17 factors compared between the two stocks.

How does PROCEPT BioRobotics compare to Integer?

Integer (NYSE:ITGR) and PROCEPT BioRobotics (NASDAQ:PRCT) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.

Integer presently has a consensus price target of $109.86, indicating a potential downside of 12.32%. PROCEPT BioRobotics has a consensus price target of $28.00, indicating a potential upside of 34.42%. Given PROCEPT BioRobotics' stronger consensus rating and higher possible upside, analysts clearly believe PROCEPT BioRobotics is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
PROCEPT BioRobotics	2 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.19

In the previous week, PROCEPT BioRobotics had 14 more articles in the media than Integer. MarketBeat recorded 38 mentions for PROCEPT BioRobotics and 24 mentions for Integer. Integer's average media sentiment score of 0.57 beat PROCEPT BioRobotics' score of 0.24 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	11 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PROCEPT BioRobotics	11 Very Positive mention(s)	0 Positive mention(s)	25 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Integer has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.30	$102.81M	$3.66	34.23
PROCEPT BioRobotics	$308.05M	3.87	-$95.57M	-$1.94	N/A

Integer has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, PROCEPT BioRobotics has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market.

Integer has a net margin of 6.97% compared to PROCEPT BioRobotics' net margin of -32.53%. Integer's return on equity of 12.79% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%

99.3% of Integer shares are held by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are held by institutional investors. 1.1% of Integer shares are held by insiders. Comparatively, 4.0% of PROCEPT BioRobotics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Integer beats PROCEPT BioRobotics on 9 of the 17 factors compared between the two stocks.

How does PROCEPT BioRobotics compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and PROCEPT BioRobotics (NASDAQ:PRCT) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations.

In the previous week, PROCEPT BioRobotics had 33 more articles in the media than iRhythm Technologies. MarketBeat recorded 38 mentions for PROCEPT BioRobotics and 5 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.08 beat PROCEPT BioRobotics' score of 0.24 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PROCEPT BioRobotics	11 Very Positive mention(s)	0 Positive mention(s)	25 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

iRhythm Technologies has a beta of 1.3, suggesting that its share price is 30% more volatile than the broader market. Comparatively, PROCEPT BioRobotics has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market.

89.5% of PROCEPT BioRobotics shares are held by institutional investors. 1.0% of iRhythm Technologies shares are held by insiders. Comparatively, 4.0% of PROCEPT BioRobotics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

iRhythm Technologies currently has a consensus price target of $179.93, indicating a potential upside of 49.63%. PROCEPT BioRobotics has a consensus price target of $28.00, indicating a potential upside of 34.42%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts plainly believe iRhythm Technologies is more favorable than PROCEPT BioRobotics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
PROCEPT BioRobotics	2 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.19

iRhythm Technologies has higher revenue and earnings than PROCEPT BioRobotics. iRhythm Technologies is trading at a lower price-to-earnings ratio than PROCEPT BioRobotics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$825.34M	4.80	-$44.55M	-$0.43	N/A
PROCEPT BioRobotics	$308.05M	3.87	-$95.57M	-$1.94	N/A

iRhythm Technologies has a net margin of -1.69% compared to PROCEPT BioRobotics' net margin of -32.53%. iRhythm Technologies' return on equity of 10.11% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-1.69%	10.11%	1.53%
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%

Summary

iRhythm Technologies beats PROCEPT BioRobotics on 13 of the 17 factors compared between the two stocks.

How does PROCEPT BioRobotics compare to Pulse Biosciences?

Pulse Biosciences (NASDAQ:PLSE) and PROCEPT BioRobotics (NASDAQ:PRCT) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings.

PROCEPT BioRobotics has a net margin of -32.53% compared to Pulse Biosciences' net margin of -6,755.78%. PROCEPT BioRobotics' return on equity of -30.62% beat Pulse Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulse Biosciences	-6,755.78%	-94.42%	-79.96%
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%

In the previous week, PROCEPT BioRobotics had 27 more articles in the media than Pulse Biosciences. MarketBeat recorded 38 mentions for PROCEPT BioRobotics and 11 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 1.14 beat PROCEPT BioRobotics' score of 0.24 indicating that Pulse Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pulse Biosciences	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PROCEPT BioRobotics	11 Very Positive mention(s)	0 Positive mention(s)	25 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Pulse Biosciences has higher earnings, but lower revenue than PROCEPT BioRobotics. Pulse Biosciences is trading at a lower price-to-earnings ratio than PROCEPT BioRobotics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulse Biosciences	$350K	9,406.63	-$72.78M	-$1.18	N/A
PROCEPT BioRobotics	$308.05M	3.87	-$95.57M	-$1.94	N/A

Pulse Biosciences currently has a consensus target price of $45.25, suggesting a potential downside of 4.88%. PROCEPT BioRobotics has a consensus target price of $28.00, suggesting a potential upside of 34.42%. Given PROCEPT BioRobotics' higher possible upside, analysts clearly believe PROCEPT BioRobotics is more favorable than Pulse Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulse Biosciences	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
PROCEPT BioRobotics	2 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.19

Pulse Biosciences has a beta of 1.61, suggesting that its stock price is 61% more volatile than the broader market. Comparatively, PROCEPT BioRobotics has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market.

77.0% of Pulse Biosciences shares are held by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are held by institutional investors. 74.0% of Pulse Biosciences shares are held by company insiders. Comparatively, 4.0% of PROCEPT BioRobotics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

PROCEPT BioRobotics beats Pulse Biosciences on 9 of the 17 factors compared between the two stocks.

Get PROCEPT BioRobotics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PRCT vs. The Competition

Export

Metric	PROCEPT BioRobotics	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.19B	$5.86B	$7.20B	$12.91B
Dividend Yield	N/A	1.75%	2.54%	11.28%
P/E Ratio	-10.74	25.92	273.16	25.45
Price / Sales	3.87	67.90	634.64	94.08
Price / Cash	N/A	33.03	76.74	53.00
Price / Book	3.51	6.18	12.98	6.14
Net Income	-$95.57M	$149.01M	$3.48B	$348.86M
7 Day Performance	-3.92%	-0.24%	0.13%	-0.80%
1 Month Performance	15.72%	6.18%	7.08%	4.13%
1 Year Performance	-48.15%	6.30%	24.67%	15.17%

PROCEPT BioRobotics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PRCT PROCEPT BioRobotics	3.6348 of 5 stars	$20.83 +1.1%	$28.00 +34.4%	-48.1%	$1.19B	$308.05M	N/A	430	Trending News
HAE Haemonetics	2.6678 of 5 stars	$108.34 -0.4%	$97.56 -10.0%	+90.1%	$4.95B	$1.35B	53.11	3,009	Analyst Revision
LIVN LivaNova	2.3975 of 5 stars	$78.26 -0.6%	$83.50 +6.7%	+42.5%	$4.34B	$1.39B	23.15	3,300	Positive News
ITGR Integer	2.7027 of 5 stars	$124.90 -0.2%	$109.86 -12.0%	+16.5%	$4.26B	$1.85B	34.12	11,000	News Coverage Positive News Analyst Revision
IRTC iRhythm Technologies	4.227 of 5 stars	$125.25 -2.5%	$179.93 +43.7%	-29.3%	$4.24B	$747.14M	N/A	2,400

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PRCT) was last updated on 8/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PROCEPT BioRobotics (PRCT) Competitors

PRCT vs. HAE, LIVN, ITGR, IRTC, and PLSE

How does PROCEPT BioRobotics compare to Haemonetics?

Summary

How does PROCEPT BioRobotics compare to LivaNova?

Summary

How does PROCEPT BioRobotics compare to Integer?

Summary

How does PROCEPT BioRobotics compare to iRhythm Technologies?

Summary

How does PROCEPT BioRobotics compare to Pulse Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRCT vs. The Competition

PROCEPT BioRobotics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

PROCEPT BioRobotics (PRCT) Competitors

PRCT vs. HAE, LIVN, ITGR, IRTC, and PLSE

How does PROCEPT BioRobotics compare to Haemonetics?

Which has preferable earnings and valuation, HAE or PRCT?

Do institutionals & insiders hold more shares of HAE or PRCT?

Which has more risk and volatility, HAE or PRCT?

Do analysts prefer HAE or PRCT?

Is HAE or PRCT more profitable?

Does the media refer more to HAE or PRCT?

Summary

How does PROCEPT BioRobotics compare to LivaNova?

Does the media refer more to PRCT or LIVN?

Which has more risk & volatility, PRCT or LIVN?

Which has stronger earnings and valuation, PRCT or LIVN?

Do insiders and institutionals have more ownership in PRCT or LIVN?

Do analysts prefer PRCT or LIVN?

Is PRCT or LIVN more profitable?

Summary

How does PROCEPT BioRobotics compare to Integer?

Do analysts rate ITGR or PRCT?

Does the media favor ITGR or PRCT?

Which has preferable earnings and valuation, ITGR or PRCT?

Which has more risk and volatility, ITGR or PRCT?

Is ITGR or PRCT more profitable?

Do insiders & institutionals believe in ITGR or PRCT?

Summary

How does PROCEPT BioRobotics compare to iRhythm Technologies?

Does the media prefer IRTC or PRCT?

Which has more volatility & risk, IRTC or PRCT?

Do insiders & institutionals hold more shares of IRTC or PRCT?

Do analysts rate IRTC or PRCT?

Which has stronger valuation and earnings, IRTC or PRCT?

Is IRTC or PRCT more profitable?

Summary

How does PROCEPT BioRobotics compare to Pulse Biosciences?

Is PLSE or PRCT more profitable?

Does the media favor PLSE or PRCT?

Which has higher earnings & valuation, PLSE or PRCT?

Do analysts rate PLSE or PRCT?

Which has more risk & volatility, PLSE or PRCT?

Do insiders & institutionals have more ownership in PLSE or PRCT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRCT vs. The Competition

PROCEPT BioRobotics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools